Healthpeak Properties Inc.
Moat Score — Healthpeak Properties Inc.
Total Moat Score
11 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 1 / 5 | As a REIT, Healthpeak owns real estate rather than a consumer-facing brand or protected technology, so intangible-asset advantages are minimal beyond institutional reputation with tenants and capital partners. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | Scale and an investment-grade balance sheet give Healthpeak access to lower-cost capital and joint-venture partnerships (e.g., with Brookfield) than smaller REITs, supporting more efficient development and acquisition economics. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 2 / 5 | Rents are set through long-term leases tied to market rates, giving Healthpeak limited near-term pricing flexibility; life science leasing in particular has faced softness and elevated new supply pressuring rents in some submarkets. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Commercial real estate ownership does not exhibit network effects between tenants. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Life science tenants face high switching costs given the expense and complexity of building out specialized lab infrastructure elsewhere, and outpatient medical tenants are often tied to hospital campus proximity, both supporting long-duration leases. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | Purpose-built life science lab buildings in premier innovation clusters (San Diego, Bay Area, Boston/Cambridge) are expensive and technically complex to construct, creating real barriers to new supply, though elevated recent construction has temporarily loosened this dynamic. |